Prospective, open labelled, phase II, monocenter trial to combine partial surgery resection and protontherapy to management paediatric craniopharyngioma.
This study is phase II prospective, open labelled, phase ii, monocenter. The main objective is to evaluate the fractionated high precision radiotherapy with a dose of 59,5 Gy (1,7 Gy daily, 5 fractions per week).
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Enrollment
33
59,5 Gy (1,7 Gy daily, 5 fractions per week).
Institut Curie
Paris, France
Groupe Hospitalier Necker Enfants Malades
Paris, France
Gustave Roussy
Villejuif, France
local control rate at 3 years of a minimally aggressive surgical resection, followed by fractionated high precision radiotherapy
Time frame: at 3 years
visual pathway tolerance according to NCI-CTC v3.0 scale
Time frame: through study completion, up to 9 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.